Correlation Between Recursion Pharmaceuticals and KEMPER
Specify exactly 2 symbols:
By analyzing existing cross correlation between Recursion Pharmaceuticals and KEMPER P DEL, you can compare the effects of market volatilities on Recursion Pharmaceuticals and KEMPER and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of KEMPER. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and KEMPER.
Diversification Opportunities for Recursion Pharmaceuticals and KEMPER
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Recursion and KEMPER is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and KEMPER P DEL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KEMPER P DEL and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with KEMPER. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KEMPER P DEL has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and KEMPER go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and KEMPER
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 14.04 times more return on investment than KEMPER. However, Recursion Pharmaceuticals is 14.04 times more volatile than KEMPER P DEL. It trades about 0.03 of its potential returns per unit of risk. KEMPER P DEL is currently generating about 0.01 per unit of risk. If you would invest 716.00 in Recursion Pharmaceuticals on September 14, 2024 and sell it today you would lose (30.00) from holding Recursion Pharmaceuticals or give up 4.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 93.13% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. KEMPER P DEL
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| KEMPER P DEL |
Recursion Pharmaceuticals and KEMPER Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and KEMPER
The main advantage of trading using opposite Recursion Pharmaceuticals and KEMPER positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, KEMPER can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KEMPER will offset losses from the drop in KEMPER's long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| KEMPER vs. AEP TEX INC | KEMPER vs. US BANK NATIONAL | KEMPER vs. Recursion Pharmaceuticals | KEMPER vs. SoundHound AI |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |